[Evaluation of permanent disability levels in occupational pulmonary diseases].

Comment évaluer en 2019 les taux d’incapacité permanente des pathologies professionnelles pulmonaires ?

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 23 07 2018
accepted: 30 07 2018
pubmed: 25 3 2019
medline: 27 8 2019
entrez: 24 3 2019
Statut: ppublish

Résumé

Compensation for occupational pulmonary diseases requires the establishment of guidelines based on standardized and objective criteria, in order to provide compensation that is as fair as possible to patients who suffer from them. A review of the elements necessary for the examination of an individual file was carried out by a working group. It is accepted that respiratory functional exploration is the key element in assessing the level of permanent disability in all of these conditions, with the exception of thoracic malignancies. Guiding scales have been developed for the respiratory impairment of three types of conditions: occupational asthma, thoracic malignancy, and other respiratory diseases. Additional criteria for increasing the permanent disability level are also proposed in order to take into account professional prejudice, in particular the possibility or not of continuing the occupational activity, in the same job or after changing to another. For certain respiratory diseases, a periodic reassessment of the initially attributed permanent disability level is recommended as well as the initial one at the time of definitive cessation of occupational activity.

Identifiants

pubmed: 30902443
pii: S0761-8425(18)30972-0
doi: 10.1016/j.rmr.2018.07.007
pii:
doi:

Types de publication

Journal Article

Langues

fre

Pagination

307-325

Informations de copyright

Copyright © 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

J-C Pairon (JC)

Service de pathologies professionnelles et de l'environnement, Institut Santé-Travail Paris-Est, CHI Créteil, 40, avenue de Verdun, 94010 Créteil, France; Inserm U955, faculté de médecine, université Paris-Est Créteil, 8, rue du Général-Sarrail, 94010 Créteil, France. Electronic address: jc.pairon@chicreteil.fr.

H Azoury (H)

ELSM, région de l'Hérault, CNAM, 34000 Montpellier, France.

M Catto (M)

Service de réhabilitation respiratoire, 20, rue Henri-Barbusse, 59374 Loos cedex, France.

J-C Dalphin (JC)

Service de pneumologie, hôpital Jean-Minjoz, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon, France.

J-F Gehanno (JF)

Service de médecine du travail et pathologie professionnelle, CHU Rouen, 1, rue de Germont, 76031 Rouen cedex, France.

B Housset (B)

Inserm U955, faculté de médecine, université Paris-Est Créteil, 8, rue du Général-Sarrail, 94010 Créteil, France; Service de pneumologie, CHI Créteil, 40, avenue de Verdun, 94010 Créteil, France.

J-P L'huillier (JP)

Service de pathologies professionnelles et de l'environnement, Institut Santé-Travail Paris-Est, CHI Créteil, 40, avenue de Verdun, 94010 Créteil, France; Cabinet de pneumologie, 114, avenue du Bac, 94210 La Varenne Saint-Hilaire, France.

S Serveau (S)

Mutualité sociale agricole, MSA Loire-Atlantique Vendée, 44000 Nantes, France.

C Straus (C)

Pôle PRAGUES, département « R3S », service d'explorations fonctionnelles de la respiration, de l'exercice et de la dyspnée, groupe hospitalier Pitié-Salpêtrière Charles Foix, Assistance publique-Hôpitaux de Paris, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Inserm, UMRS 1158, neurophysiologie respiratoire expérimentale et clinique, Sorbonne université, 75013 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH